Antimicrobial Susceptibility Testing Symposium and Therapeutic Drug Monitoring Workshop

 

Strong associations exist between drug exposure and patient outcome for many antimicrobials. Therapeutic drug monitoring (TDM) is an obvious method to apply to ensure more patients achieve effective drug concentrations, and should be considered standard-of-care for most antimicrobials. However, there remains uncertainty and inconsistency with practice for which patients would most benefit from TDM, which antimicrobial concentration targets should be used and what feasible methods could be applied to effectively change doses. In this Symposium, we will address these issues as they relate to antibacterials, antifungals and antimycobacterials. We will also present new technological advances that improve the feasibility and accuracy of antimicrobial TDM and specific considerations for key settings including paediatrics and outpatients (and critically ill patients of course!) as well as the place of dosing software. Please join us and hear from leading practitioners and scientists in this area!

Antimicrobial susceptibility testing is a key component of the management of patients with bacterial and fungal infections.  In the setting of increasing prevalence of multi-drug resistant organisms, susceptibility testing is crucial.  The aim of this workshop is to provide opportunity to understand the process of susceptibility testing along with rationale for setting breakpoints, epidemiologic cutoffs and the potential for new AST methods to improve clinical care.

This 2 day symposium will provide an opportunity to improve your knowledge and understanding of how to apply susceptibility testing.  In addition, an extra opportunity will be available for a small cohort of 24 people to spend a half day in the laboratory performing and interpreting susceptibility testing by common methods.

Speakers include Prof John Turnidge - EUCAST Scientific Secretary and ACSQHC Senior Clinical Advisor and

Dr Gunnar Kahlmeter - MD, EUCAST Steering committee and Head of the EUCAST Development Laboratory

Antimicrobial Susceptibility Testing Symposium and Therapeutic Drug Monitoring Workshop

Wed 29 Apr 2020 8:30amSat 2 May 2020 5:00pm
Antimicrobial Susceptibility Testing (AST) Symposium $300.00
Therapeutic Drug Monitoring (TDM) Workshop $200.00
AST + TDM $400.00
AST + Wet Lab 350.00
AST + TDM + Wet Lab $450.00

Contacts

Nermin Karamujic